glp 1 weight loss does it work GLP-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Drugs for Weight Loss

Lancet Diab Endocrinol 6(3):237248 Ethics declarations Disclosures Dr

With continued progress in our understanding of the workings and potential therapeutic advantages of GLP-1RA, these agents could radically alter the control of these conditions and improve the patients prognosis

Although some in-class heterogeneity has been observed, these CVOTs have shown that DPP-4i and GLP-RAs are safe relative to major cardiovascular outcomes

While FDA approval is specific to HIV-associated lipodystrophy, tesamorelin is prescribed off-label for visceral fat reduction and body composition optimization in broader populations

Semaglutide (Wegovy) FDA-approved for: Chronic weight management Treatment of Metabolic dysfunction-Associated Steatohepatitis (MASH) approved August 2025 FDA-indicated for: Reducing risk of heart attack, stroke, and cardiovascular death in adults with established cardiovascular disease who are obese or overweight Weekly injection Clinical trials show an average weight loss of 1215% of body weight